Medicinal product name | Bicalutamide TEVA 50 mg film-coated tablets |
||||||
---|---|---|---|---|---|---|---|
Pharmaceutical form | Film-coated tablet | ||||||
Strength | 50 mg | ||||||
Information from the MAH on shortages | No information on expected shortages | ||||||
Availability of medicinal product |
|
||||||
Legal status | Reimbursed medicines reference product |
Prescription (Pr.)||||||
Package leaflet | 09-06-2022 | ||||||
Summary of product characteristics | 09-06-2022 | ||||||
ATC code | L02BB03 – Endocrine therapy |
Medicinal products (10)
Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
---|---|---|---|---|---|---|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (50 mg) |
PVC/PVDC/Al blister | 07-0139-01 |
Labelling text May 24, 2018 |
|
Is available (according to the information provided by wholesalers) (53 containers) |
Tamro, Recipe Plus, Magnum Medical, Euroaptieka |
N28 (50 mg) |
PVC/PVDC/Al blister |
€ 13.91 * |
07-0139-02 |
Labelling text May 24, 2018 |
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30 (50 mg) |
PVC/PVDC/Al blister | 07-0139-03 |
Labelling text May 24, 2018 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N40 (50 mg) |
PVC/PVDC/Al blister | 07-0139-04 |
Labelling text May 24, 2018 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (50 mg) |
PVC/PVDC/Al blister | 07-0139-05 |
Labelling text May 24, 2018 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N84 (50 mg) |
PVC/PVDC/Al blister | 07-0139-06 |
Labelling text May 24, 2018 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N90 (50 mg) |
PVC/PVDC/Al blister | 07-0139-07 |
Labelling text May 24, 2018 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (50 mg) |
PVC/PVDC/Al blister | 07-0139-08 |
Labelling text May 24, 2018 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N56 (50 mg) |
PVC/PVDC/Al blister | 07-0139-09 |
Labelling text May 24, 2018 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50 (50 mg) |
PVC/PVDC/Al blister | 07-0139-10 |
Labelling text May 24, 2018 |
Registration information
Marketing authorisation No. | 07-0139 |
---|---|
Date of authorisation | Jun 12, 2007 |
Marketing authorisation holder, country | Teva Pharma B.V., Netherlands |